SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-034156
Filing Date
2023-07-24
Accepted
2023-07-24 19:39:09
Documents
1
Period of Report
2023-07-21

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3914
  Complete submission text file 0000950170-23-034156.txt   5255
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Issuer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TSCAN THERAPEUTICS, INC. 880 WINTER STREET WALTHAM MA 02451
Business Address
Dworak Leiden (Reporting) CIK: 0001986012 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40603 | Film No.: 231106151